Intestinal Toxicity Assessment with Patient-Derived Organoids
Dr. Martin Stahl describes the use of patient-derived intestinal organoids to assess the toxicity of potential therapeutic compounds and study barrier function in a human-specific model system.
Featured Webinars
Photoacoustic Imaging in Angiotensin II Induced Cardiac Hypertrophy Mice
Wednesday, April 17, 2024
Webinar Host: FUJIFILM VisualSonics Inc.
Preclinical Animal Models of IBD, GVHD, and Pulmonary Disease
Thursday, April 4, 2024
Sponsor: Biomodels, LLC
Partner: Scientist.com
Applications of Human Intestinal Organoid Cultures in Drug Discovery
Wednesday, April 3, 2024
Sponsor: STEMCELL Technologies Inc.
Partner: Scientist.com
Advertisement
